Norox®150

Roxithromycin Tablet

Composition

Each Norox®150  tablet contains Roxithromycin IP 150mg 

Indications

Norox®150  is indicated in the treatment of mild to moderate infections caused by susceptible organisms including:

Sinusitis, tonsillitis, otitis media and pharyngitis infections caused by susceptible organisms including: Sinusitis, tonsillitis, otitis media and pharyngitis caused by Group A beta-haemolytic Streptococci and Streptococcus pneumoniae.

Acute bronchitis and pneumonia caused by Streptococcus pneumoniae.

Atypical pneumonia caused by Mycoplasma pneumonia.

Erysipelas and pyoderma caused by Staphylococcus aureus and Group A beta-haemolytic Streptococci.

Non-gonococcal urethritis in males, due to Chlamydia trachomatis and Ureaplasma urealyticum.

PRESENTATION & PACKAGING

Norox®150    White, biconvex film coated tablet
                     Blister strip pack of 10s.

For Precautions and Drug Interactions please consult full Product Information or write to us.

® - Registered Trade Mark of Quality Innovations and Pharmaceuticals (India) Pvt Ltd.

Disclaimer

 The drug information is intended for the use of a registered medical practitioner only. If you are not a medical professional, you should note that this document does not provide professional medical advice and is not intended to replace personal consultation with a qualified physician and should not be relied upon solely for final treatment decisions. Company reserves right to change Product presentation, display, capsule colors, tablet size,forms etc without prior notice.